Home » Topics » Disease categories and therapies » Urology

Urology
RSS

AstraZeneca and Ardelyx sign licensing deal for NHE-3 inhibitor program

Oct. 10, 2012

Mirabegron safe in male patients with bladder outlet obstruction

Oct. 8, 2012

Bayer Yakuhin seeks additional approval for Fosrenol chewable tablets and granules in Japan

Oct. 5, 2012

Votubia recommended for approval in Europe

Sep. 26, 2012

CHMP gives positive opinion on Cialis in new indication

Sep. 26, 2012

Cytochroma begins first of two identical phase III studies of CTAP-101

Sep. 21, 2012

Nymox provides update on phase III BPH study

Sep. 19, 2012

Takeda obtains U.K. license for erectile dysfunction medication

Sep. 14, 2012

Santaris Pharma discloses new oligonucleotides

Sep. 12, 2012

Targacept to develop TC-5214 in overactive bladder

Sep. 6, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...